20/20 BioLabs Lists on Nasdaq Awaiting FDA Approval
The diagnostics firm enters public markets as it works to secure clinical clearance for its home-based cancer screening tests.
Live Poll
Would you use home-collection laboratory tests to screen for chronic diseases and cancer?